Retatrutide dosing errors and adverse events
Discussed in 1 analyzed podcast episode across 1 show
Discussed On
Episodes
On The Pen GLP-1 News · May 5, 2026
He Took Retatrutide 40mg and Proved a Point
Gray market GLP-1 access and safety risksFoundae (orfoglutide) liver safety signalsRegulatory enforcement against compounded GLP-1sState medical board pressure on cliniciansTelehealth litigation and market consolidation
View Analysis